The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Correlation of TOP2A expression in HER2-positive breast cancer with pathologic response and clinical outcomes in patients undergoing neoadjuvant treatment based on anthracycline.
Elizabeth S. Santos
No relevant relationships to disclose
Felipe D'Almeida Costa
No relevant relationships to disclose
Stephania Bezerra
No relevant relationships to disclose
Rafael Costa Lessa
No relevant relationships to disclose
Vladmir Claudio Cordeiro De Lima
No relevant relationships to disclose
Debora De Melo Gagliato
No relevant relationships to disclose
Geraldine Eltz Lima
No relevant relationships to disclose
Marcello Ferretti Fanelli
No relevant relationships to disclose
Rafael Malagoli Rocha
No relevant relationships to disclose
Alexandre Andre Balieiro da Costa
No relevant relationships to disclose
Augusto Akikubo Rodrigues Pereira
No relevant relationships to disclose
Fernando Vidigal Padua
No relevant relationships to disclose
Carlos Eduardo Pires Sousa
No relevant relationships to disclose
Paulo Henrique Aires Freitas
No relevant relationships to disclose
Flavio Augusto Ismael Pinto
No relevant relationships to disclose
Newton Augusto Ferreira Rodrigues
No relevant relationships to disclose
Carlos Frederico Lopes Benevides
No relevant relationships to disclose